{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T15:59:15Z","timestamp":1792425555010,"version":"4.5.0"},"reference-count":135,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archives of Cardiovascular Diseases"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.acvd.2021.08.004","type":"journal-article","created":{"date-parts":[[2021,10,8]],"date-time":"2021-10-08T00:20:03Z","timestamp":1633652403000},"page":"748-760","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":56,"title":["The role of hyperglycaemia in the development of diabetic cardiomyopathy"],"prefix":"10.1016","volume":"114","author":[{"given":"Magali Samia","family":"El Hayek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Ernande","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9866-9081","authenticated-orcid":false,"given":"Jean-Pierre","family":"Benitah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0009-2884","authenticated-orcid":false,"given":"Ana-Maria","family":"Gomez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laetitia","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.acvd.2021.08.004_bib0680","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.diabres.2018.02.023","article-title":"IDF Diabetes Atlas: global estimates of diabetes prevalence for 2017 and projections for 2045","volume":"138","author":"Cho","year":"2018","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.acvd.2021.08.004_bib0685","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1001\/jama.1979.03290450033020","article-title":"Diabetes and cardiovascular disease. The Framingham study","volume":"241","author":"Kannel","year":"1979","journal-title":"JAMA"},{"key":"10.1016\/j.acvd.2021.08.004_bib0690","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/0002-9149(72)90595-4","article-title":"New type of cardiomyopathy associated with diabetic glomerulosclerosis","volume":"30","author":"Rubler","year":"1972","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.acvd.2021.08.004_bib0695","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1172\/JCI108843","article-title":"Evidence for cardiomyopathy in familial diabetes mellitus","volume":"60","author":"Regan","year":"1977","journal-title":"J Clin Invest"},{"key":"10.1016\/j.acvd.2021.08.004_bib0700","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1097\/HJH.0b013e3283331169","article-title":"Diabetes and incident heart failure in hypertensive and normotensive participants of the Strong Heart Study","volume":"28","author":"de Simone","year":"2010","journal-title":"J Hypertens"},{"key":"10.1016\/j.acvd.2021.08.004_bib0705","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1161\/01.CIR.101.19.2271","article-title":"Impact of diabetes on cardiac structure and function: the Strong Heart Study","volume":"101","author":"Devereux","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.acvd.2021.08.004_bib0710","doi-asserted-by":"crossref","first-page":"105","DOI":"10.2337\/diab.23.2.105","article-title":"Morbidity and mortality in diabetics in the Framingham population. Sixteen year follow-up study","volume":"23","author":"Garcia","year":"1974","journal-title":"Diabetes"},{"key":"10.1016\/j.acvd.2021.08.004_bib0715","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/0002-9149(74)90089-7","article-title":"Role of diabetes in congestive heart failure: the Framingham study","volume":"34","author":"Kannel","year":"1974","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.acvd.2021.08.004_bib0720","doi-asserted-by":"crossref","first-page":"612","DOI":"10.2337\/diacare.28.3.612","article-title":"The association between glucose abnormalities and heart failure in the population-based Reykjavik study","volume":"28","author":"Thrainsdottir","year":"2005","journal-title":"Diabetes Care"},{"key":"10.1016\/j.acvd.2021.08.004_bib0725","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1002\/ejhf.455","article-title":"Mean HbA1c and mortality in diabetic individuals with heart failure: a population cohort study","volume":"18","author":"Elder","year":"2016","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.acvd.2021.08.004_bib0730","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1093\/eurjhf\/hfs156","article-title":"Association between glycated haemoglobin and the risk of congestive heart failure in diabetes mellitus: systematic review and meta-analysis","volume":"15","author":"Erqou","year":"2013","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.acvd.2021.08.004_bib0735","doi-asserted-by":"crossref","first-page":"2668","DOI":"10.1161\/01.CIR.103.22.2668","article-title":"Glycemic control and heart failure among adult patients with diabetes","volume":"103","author":"Iribarren","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.acvd.2021.08.004_bib0740","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1161\/CIRCULATIONAHA.113.008476","article-title":"Myocardial contractile dysfunction is associated with impaired mitochondrial function and dynamics in type 2 diabetic but not in obese patients","volume":"130","author":"Montaigne","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.acvd.2021.08.004_bib0745","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1038\/nature05815","article-title":"Cycling of O-linked beta-N-acetylglucosamine on nucleocytoplasmic proteins","volume":"446","author":"Hart","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.acvd.2021.08.004_bib0750","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1161\/CIRCULATIONAHA.107.730515","article-title":"Cardioprotection by N-acetylglucosamine linkage to cellular proteins","volume":"117","author":"Jones","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.acvd.2021.08.004_bib0755","doi-asserted-by":"crossref","first-page":"H1391","DOI":"10.1152\/ajpheart.00285.2007","article-title":"Increased O-GlcNAc levels during reperfusion lead to improved functional recovery and reduced calpain proteolysis","volume":"293","author":"Liu","year":"2007","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.acvd.2021.08.004_bib0760","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1016\/j.bbadis.2016.08.012","article-title":"O-GlcNAcylation, enemy or ally during cardiac hypertrophy development?","volume":"1862","author":"Mailleux","year":"2016","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.acvd.2021.08.004_bib0765","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.phrs.2016.12.016","article-title":"Insights into the role of maladaptive hexosamine biosynthesis and O-GlcNAcylation in development of diabetic cardiac complications","volume":"116","author":"Qin","year":"2017","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.acvd.2021.08.004_bib0770","doi-asserted-by":"crossref","first-page":"R689","DOI":"10.1152\/ajpregu.00548.2011","article-title":"Excess protein O-GlcNAcylation and the progression of diabetic cardiomyopathy","volume":"303","author":"Fricovsky","year":"2012","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10.1016\/j.acvd.2021.08.004_bib0775","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1161\/01.RES.0000165478.06813.58","article-title":"Adenovirus-mediated overexpression of O-GlcNAcase improves contractile function in the diabetic heart","volume":"96","author":"Hu","year":"2005","journal-title":"Circ Res"},{"key":"10.1016\/j.acvd.2021.08.004_bib0780","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s10741-013-9374-y","article-title":"Advanced glycation end products: role in pathology of diabetic cardiomyopathy","volume":"19","author":"Bodiga","year":"2014","journal-title":"Heart Fail Rev"},{"key":"10.1016\/j.acvd.2021.08.004_bib0785","doi-asserted-by":"crossref","first-page":"2651","DOI":"10.1172\/JCI44747","article-title":"Phosphodiesterase 4B in the cardiac L-type Ca(2)(+) channel complex regulates Ca(2)(+) current and protects against ventricular arrhythmias in mice","volume":"121","author":"Leroy","year":"2011","journal-title":"J Clin Invest"},{"key":"10.1016\/j.acvd.2021.08.004_bib0790","first-page":"633","article-title":"Risk Factors","volume":"379","author":"Rawshani","year":"2018","journal-title":"Mortality, and Cardiovascular Outcomes in Patients with Type 2 Diabetes. N Engl J Med"},{"key":"10.1016\/j.acvd.2021.08.004_bib0795","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1016\/j.jacc.2014.08.036","article-title":"Noncardiac comorbidities in heart failure with reduced versus preserved ejection fraction","volume":"64","author":"Mentz","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.acvd.2021.08.004_bib0800","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.jacc.2003.11.024","article-title":"Influence of diabetes and diabetes-gender interaction on the risk of death in patients hospitalized with congestive heart failure","volume":"43","author":"Gustafsson","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.acvd.2021.08.004_bib0805","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1093\/eurheartj\/ehn153","article-title":"Impact of diabetes on outcomes in patients with low and preserved ejection fraction heart failure: an analysis of the Candesartan in Heart failure: assessment of Reduction in Mortality and morbidity (CHARM) programme","volume":"29","author":"MacDonald","year":"2008","journal-title":"Eur Heart J"},{"key":"10.1016\/j.acvd.2021.08.004_bib0810","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1161\/CIRCULATIONAHA.116.024593","volume":"135","author":"Kristensen","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.acvd.2021.08.004_bib0815","doi-asserted-by":"crossref","first-page":"699","DOI":"10.2337\/diacare.27.3.699","article-title":"Heart failure prevalence, incidence, and mortality in the elderly with diabetes","volume":"27","author":"Bertoni","year":"2004","journal-title":"Diabetes Care"},{"key":"10.1016\/j.acvd.2021.08.004_bib0820","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1093\/eurjhf\/hfs153","article-title":"Association between diabetes mellitus and post-discharge outcomes in patients hospitalized with heart failure: findings from the EVEREST trial","volume":"15","author":"Sarma","year":"2013","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.acvd.2021.08.004_bib0825","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.acvd.2017.10.004","article-title":"Adverse impact of diabetes mellitus on left ventricular remodelling in patients with chronic primary mitral regurgitation","volume":"111","author":"Ernande","year":"2018","journal-title":"Arch Cardiovasc Dis"},{"key":"10.1016\/j.acvd.2021.08.004_bib0830","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1161\/CIRCULATIONAHA.107.707737","article-title":"In vivo characterization of murine myocardial perfusion with myocardial contrast echocardiography: validation and application in nitric oxide synthase 3 deficient mice","volume":"116","author":"Raher","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.acvd.2021.08.004_bib0835","doi-asserted-by":"crossref","first-page":"H2495","DOI":"10.1152\/ajpheart.00139.2008","article-title":"A short duration of high-fat diet induces insulin resistance and predisposes to adverse left ventricular remodeling after pressure overload","volume":"295","author":"Raher","year":"2008","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.acvd.2021.08.004_bib0840","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1001\/jama.1994.03510350050036","article-title":"Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study","volume":"271","author":"Benjamin","year":"1994","journal-title":"JAMA"},{"key":"10.1016\/j.acvd.2021.08.004_bib0845","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.amjcard.2011.03.004","article-title":"Meta-analysis of cohort and case-control studies of type 2 diabetes mellitus and risk of atrial fibrillation","volume":"108","author":"Huxley","year":"2011","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.acvd.2021.08.004_bib0850","doi-asserted-by":"crossref","first-page":"e0170955","DOI":"10.1371\/journal.pone.0170955","article-title":"Serum glycated hemoglobin level as a predictor of atrial fibrillation: A systematic review with meta-analysis and meta-regression","volume":"12","author":"Qi","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.acvd.2021.08.004_bib0855","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1056\/NEJMoa0806470","article-title":"10-year follow-up of intensive glucose control in type 2 diabetes","volume":"359","author":"Holman","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.acvd.2021.08.004_bib0860","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.yjmcc.2013.03.005","article-title":"Dysfunctional ryanodine receptors in the heart: new insights into complex cardiovascular diseases","volume":"58","author":"Marx","year":"2013","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.acvd.2021.08.004_bib0865","doi-asserted-by":"crossref","first-page":"405","DOI":"10.2337\/dc16-1889","article-title":"Association of cardiovascular risk factors and myocardial fibrosis with early cardiac dysfunction in Type 1 Diabetes: the Diabetes Control and Complications Trial\/Epidemiology of Diabetes Interventions and Complications Study","volume":"40","author":"Armstrong","year":"2017","journal-title":"Diabetes Care"},{"key":"10.1016\/j.acvd.2021.08.004_bib0870","doi-asserted-by":"crossref","first-page":"701","DOI":"10.2337\/dc15-2283","article-title":"Nine-year effects of 3.7 years of intensive glycemic control on cardiovascular outcomes","volume":"39","year":"2016","journal-title":"Diabetes Care"},{"key":"10.1016\/j.acvd.2021.08.004_bib0875","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1056\/NEJMoa1407963","article-title":"Follow-up of blood-pressure lowering and glucose control in type 2 diabetes","volume":"371","author":"Zoungas","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.acvd.2021.08.004_bib0880","doi-asserted-by":"crossref","first-page":"157","DOI":"10.2337\/dc18-1144","article-title":"Effects of severe hypoglycemia on cardiovascular outcomes and death in the veterans affairs diabetes trial","volume":"42","author":"Davis","year":"2019","journal-title":"Diabetes Care"},{"key":"10.1016\/j.acvd.2021.08.004_bib0885","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1093\/eurheartj\/ehw128","volume":"37","author":"Ponikowski","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.acvd.2021.08.004_bib0890","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.jacc.2017.04.025","volume":"70","author":"Yancy","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.acvd.2021.08.004_bib0895","doi-asserted-by":"crossref","first-page":"e147","DOI":"10.1016\/j.jacc.2013.05.019","article-title":"2013 ACCF\/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines","volume":"62","author":"Yancy","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.acvd.2021.08.004_bib0900","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/0002-9149(91)90716-X","article-title":"Echocardiographic evidence for the existence of a distinct diabetic cardiomyopathy (the Framingham Heart Study)","volume":"68","author":"Galderisi","year":"1991","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.acvd.2021.08.004_bib0905","doi-asserted-by":"crossref","DOI":"10.1016\/j.echo.2011.07.017","article-title":"Diastolic dysfunction in patients with type 2 diabetes mellitus: is it really the first marker of diabetic cardiomyopathy?","volume":"24","author":"Ernande","year":"2011","journal-title":"J Am Soc Echocardiogr"},{"key":"10.1016\/j.acvd.2021.08.004_bib0910","doi-asserted-by":"crossref","first-page":"5","DOI":"10.2337\/diacare.24.1.5","article-title":"Diastolic dysfunction in normotensive men with well-controlled type 2 diabetes: importance of maneuvers in echocardiographic screening for preclinical diabetic cardiomyopathy","volume":"24","author":"Poirier","year":"2001","journal-title":"Diabetes Care"},{"key":"10.1016\/j.acvd.2021.08.004_bib0915","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1016\/j.echo.2010.09.007","article-title":"Impaired myocardial radial function in asymptomatic patients with type 2 diabetes mellitus: a speckle-tracking imaging study","volume":"23","author":"Ernande","year":"2010","journal-title":"J Am Soc Echocardiogr"},{"key":"10.1016\/j.acvd.2021.08.004_bib0920","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1148\/radiol.12112571","article-title":"Systolic myocardial dysfunction in patients with type 2 diabetes mellitus: identification at MR imaging with cine displacement encoding with stimulated echoes","volume":"265","author":"Ernande","year":"2012","journal-title":"Radiology"},{"key":"10.1016\/j.acvd.2021.08.004_bib0925","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/S0735-1097(03)00654-5","article-title":"Patients with early diabetic heart disease demonstrate a normal myocardial response to dobutamine","volume":"42","author":"Fang","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.acvd.2021.08.004_bib0930","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.echo.2014.01.001","article-title":"Longitudinal myocardial strain alteration is associated with left ventricular remodeling in asymptomatic patients with type 2 diabetes mellitus","volume":"27","author":"Ernande","year":"2014","journal-title":"J Am Soc Echocardiogr"},{"key":"10.1016\/j.acvd.2021.08.004_bib0935","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1136\/heartjnl-2014-307391","article-title":"Subclinical LV dysfunction and 10-year outcomes in type 2 diabetes mellitus","volume":"101","author":"Holland","year":"2015","journal-title":"Heart"},{"key":"10.1016\/j.acvd.2021.08.004_bib0940","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/j.amjcard.2003.12.026","article-title":"Prevalence of ventricular diastolic dysfunction in asymptomatic, normotensive patients with diabetes mellitus","volume":"93","author":"Boyer","year":"2004","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.acvd.2021.08.004_bib0945","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1093\/ehjci\/jew082","article-title":"Recommendations for the evaluation of left ventricular diastolic function by echocardiography: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging","volume":"17","author":"Nagueh","year":"2016","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"10.1016\/j.acvd.2021.08.004_bib0950","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.jacc.2009.12.003","article-title":"The development of heart failure in patients with diabetes mellitus and pre-clinical diastolic dysfunction a population-based study","volume":"55","author":"From","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.acvd.2021.08.004_bib0955","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.jacc.2014.10.044","article-title":"Exercise limitation associated with asymptomatic left ventricular impairment: analogy with stage B heart failure","volume":"65","author":"Kosmala","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.acvd.2021.08.004_bib0960","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1016\/j.jacc.2017.07.792","article-title":"Clinical Implications of Echocardiographic Phenotypes of Patients With Diabetes Mellitus","volume":"70","author":"Ernande","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.acvd.2021.08.004_bib0965","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.jacc.2017.11.019","article-title":"Implications of underlying mechanisms for the recognition and management of diabetic cardiomyopathy","volume":"71","author":"Marwick","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.acvd.2021.08.004_bib0970","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1007\/s00125-014-3164-5","article-title":"Prevalence of systolic and diastolic dysfunction in patients with type 1 diabetes without known heart disease: the Thousand & 1 Study","volume":"57","author":"Jensen","year":"2014","journal-title":"Diabetologia"},{"key":"10.1016\/j.acvd.2021.08.004_bib0975","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.jcmg.2014.12.020","article-title":"Global longitudinal strain is not impaired in type 1 diabetes patients without albuminuria: the Thousand & 1 study","volume":"8","author":"Jensen","year":"2015","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.acvd.2021.08.004_bib0980","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.jacc.2005.09.030","article-title":"Increased myocardial fatty acid metabolism in patients with type 1 diabetes mellitus","volume":"47","author":"Herrero","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.acvd.2021.08.004_bib0985","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1161\/CIRCULATIONAHA.109.873273","article-title":"Relationship between coronary microvascular dysfunction and cardiac energetics impairment in type 1 diabetes mellitus","volume":"121","author":"Shivu","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.acvd.2021.08.004_bib0990","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/S2213-8587(15)00292-2","article-title":"Long-term excess risk of heart failure in people with type 1 diabetes: a prospective case-control study","volume":"3","author":"Rosengren","year":"2015","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.acvd.2021.08.004_bib0995","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehv134","article-title":"Clinical diabetic cardiomyopathy: a two-faced disease with restrictive and dilated phenotypes","volume":"36","author":"Seferovic","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.acvd.2021.08.004_bib1000","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1007\/s00125-014-3171-6","article-title":"Molecular mechanisms of diabetic cardiomyopathy","volume":"57","author":"Bugger","year":"2014","journal-title":"Diabetologia"},{"key":"10.1016\/j.acvd.2021.08.004_bib1005","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.diabet.2014.03.007","article-title":"Longitudinal left ventricular strain impairment in type 1 diabetes children and adolescents: a 2D speckle strain imaging study","volume":"40","author":"Labombarda","year":"2014","journal-title":"Diabetes Metab"},{"key":"10.1016\/j.acvd.2021.08.004_bib1010","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/00004872-200301000-00002","article-title":"Cross-linking of glycated collagen in the pathogenesis of arterial and myocardial stiffening of aging and diabetes","volume":"21","author":"Aronson","year":"2003","journal-title":"J Hypertens"},{"key":"10.1016\/j.acvd.2021.08.004_bib1015","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.diabres.2017.08.018","article-title":"Transforming growth factor beta (TGF-beta) mediates cardiac fibrosis and induces diabetic cardiomyopathy","volume":"133","author":"Yue","year":"2017","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.acvd.2021.08.004_bib1020","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.nutres.2015.11.012","article-title":"Conjugated linoleic acid prevents high glucose-induced hypertrophy and contractile dysfunction in adult rat cardiomyocytes","volume":"36","author":"Aloud","year":"2016","journal-title":"Nutr Res"},{"key":"10.1016\/j.acvd.2021.08.004_bib1025","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.yjmcc.2008.06.009","article-title":"PARP mediates structural alterations in diabetic cardiomyopathy","volume":"45","author":"Chiu","year":"2008","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.acvd.2021.08.004_bib1030","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1056\/NEJM199309303291401","article-title":"The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus","volume":"329","author":"Nathan","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1016\/j.acvd.2021.08.004_bib1035","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.1056\/NEJMoa052187","article-title":"Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes","volume":"353","author":"Nathan","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.acvd.2021.08.004_bib1040","doi-asserted-by":"crossref","first-page":"808","DOI":"10.2337\/diab.36.7.808","article-title":"Progression of incipient diabetic retinopathy during good glycemic control","volume":"36","author":"Engerman","year":"1987","journal-title":"Diabetes"},{"key":"10.1016\/j.acvd.2021.08.004_bib1045","doi-asserted-by":"crossref","first-page":"S176","DOI":"10.1016\/j.dsx.2016.03.016","article-title":"Metabolic memory phenomenon in diabetes mellitus: achieving and perspectives","volume":"10","author":"Berezin","year":"2016","journal-title":"Diabetes Metab Syndr"},{"key":"10.1016\/j.acvd.2021.08.004_bib1050","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1073\/pnas.87.1.404","article-title":"Overexpression of fibronectin induced by diabetes or high glucose: phenomenon with a memory","volume":"87","author":"Roy","year":"1990","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.acvd.2021.08.004_bib1055","doi-asserted-by":"crossref","first-page":"8891","DOI":"10.1007\/s11033-012-1756-z","article-title":"High levels of glucose induce \u201cmetabolic memory\u201d in cardiomyocyte via epigenetic histone H3 lysine 9 methylation","volume":"39","author":"Yu","year":"2012","journal-title":"Mol Biol Rep"},{"key":"10.1016\/j.acvd.2021.08.004_bib1060","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1161\/CIRCRESAHA.110.223552","article-title":"Epigenetics: mechanisms and implications for diabetic complications","volume":"107","author":"Cooper","year":"2010","journal-title":"Circ Res"},{"key":"10.1016\/j.acvd.2021.08.004_bib1065","doi-asserted-by":"crossref","DOI":"10.1152\/ajprenal.00200.2010","article-title":"The role of epigenetics in the pathology of diabetic complications","volume":"299","author":"Villeneuve","year":"2010","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.acvd.2021.08.004_bib1070","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.2337\/diabetes.54.6.1615","article-title":"The pathobiology of diabetic complications: a unifying mechanism","volume":"54","author":"Brownlee","year":"2005","journal-title":"Diabetes"},{"key":"10.1016\/j.acvd.2021.08.004_bib1075","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/35008121","article-title":"Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage","volume":"404","author":"Nishikawa","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.acvd.2021.08.004_bib1080","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1042\/CS20070166","article-title":"Molecular mechanisms for myocardial mitochondrial dysfunction in the metabolic syndrome","volume":"114","author":"Bugger","year":"2008","journal-title":"Clin Sci (Lond)"},{"key":"10.1016\/j.acvd.2021.08.004_bib1085","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1253\/circj.CJ-13-1187","article-title":"Production of reactive oxygen species in the diabetic heart. Roles of mitochondria and NADPH oxidase","volume":"78","author":"Teshima","year":"2014","journal-title":"Circ J"},{"key":"10.1016\/j.acvd.2021.08.004_bib1090","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1074\/jbc.M808518200","article-title":"Increased enzymatic O-GlcNAcylation of mitochondrial proteins impairs mitochondrial function in cardiac myocytes exposed to high glucose","volume":"284","author":"Hu","year":"2009","journal-title":"J Biol Chem"},{"key":"10.1016\/j.acvd.2021.08.004_bib1095","doi-asserted-by":"crossref","first-page":"C1561","DOI":"10.1152\/ajpcell.00076.2008","article-title":"Alterations in mitochondrial function and cytosolic calcium induced by hyperglycemia are restored by mitochondrial transcription factor A in cardiomyocytes","volume":"295","author":"Suarez","year":"2008","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1016\/j.acvd.2021.08.004_bib1100","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.2337\/diabetes.51.6.1938","article-title":"Hyperglycemia-induced apoptosis in mouse myocardium: mitochondrial cytochrome C-mediated caspase-3 activation pathway","volume":"51","author":"Cai","year":"2002","journal-title":"Diabetes"},{"key":"10.1016\/j.acvd.2021.08.004_bib1105","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1093\/abbs\/gmw079","article-title":"Activation of Na+\/K\u00b1ATPase attenuates high glucose-induced H9c2 cell apoptosis via suppressing ROS accumulation and MAPKs activities by DRm217","volume":"48","author":"Yan","year":"2016","journal-title":"Acta Biochim Biophys Sin (Shanghai)"},{"key":"10.1016\/j.acvd.2021.08.004_bib1110","doi-asserted-by":"crossref","first-page":"H118","DOI":"10.1152\/ajpheart.00932.2010","article-title":"Increased propensity for cell death in diabetic human heart is mediated by mitochondrial-dependent pathways","volume":"300","author":"Anderson","year":"2011","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.acvd.2021.08.004_bib1115","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.bbrc.2019.03.193","article-title":"High-glucose induces cardiac myocytes apoptosis through Foxo1\/GRK2 signaling pathway","volume":"513","author":"Yang","year":"2019","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.acvd.2021.08.004_bib1120","doi-asserted-by":"crossref","first-page":"13557","DOI":"10.1002\/jcp.28034","article-title":"ROS- and HIF1alpha-dependent IGFBP3 upregulation blocks IGF1 survival signaling and thereby mediates high-glucose-induced cardiomyocyte apoptosis","volume":"234","author":"Huang","year":"2019","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.acvd.2021.08.004_bib1125","doi-asserted-by":"crossref","first-page":"608","DOI":"10.2337\/diabetes.55.03.06.db05-1284","article-title":"Mechanisms of [Ca2+]i transient decrease in cardiomyopathy of db\/db type 2 diabetic mice","volume":"55","author":"Pereira","year":"2006","journal-title":"Diabetes"},{"key":"10.1016\/j.acvd.2021.08.004_bib1130","doi-asserted-by":"crossref","first-page":"H1398","DOI":"10.1152\/ajpheart.00313.2002","article-title":"Defective intracellular Ca(2+) signaling contributes to cardiomyopathy in Type 1 diabetic rats","volume":"283","author":"Choi","year":"2002","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.acvd.2021.08.004_bib1135","first-page":"173","article-title":"Alterations in Ca(2+)-channels during the development of diabetic cardiomyopathy","volume":"109","author":"Lee","year":"1992","journal-title":"Mol Cell Biochem"},{"key":"10.1016\/j.acvd.2021.08.004_bib1140","doi-asserted-by":"crossref","first-page":"2780","DOI":"10.2337\/db06-1629","article-title":"Decreased L-type Ca2+ current in cardiac myocytes of type 1 diabetic Akita mice due to reduced phosphatidylinositol 3-kinase signaling","volume":"56","author":"Lu","year":"2007","journal-title":"Diabetes"},{"key":"10.1016\/j.acvd.2021.08.004_bib1145","doi-asserted-by":"crossref","first-page":"3082","DOI":"10.2337\/diabetes.54.11.3082","article-title":"Effects of diabetes on ryanodine receptor Ca release channel (RyR2) and Ca2+ homeostasis in rat heart","volume":"54","author":"Yaras","year":"2005","journal-title":"Diabetes"},{"key":"10.1016\/j.acvd.2021.08.004_bib1150","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1124\/mol.112.078352","article-title":"Carbonylation induces heterogeneity in cardiac ryanodine receptor function in diabetes mellitus","volume":"82","author":"Shao","year":"2012","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.acvd.2021.08.004_bib1155","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s10741-013-9384-9","article-title":"Reactive carbonyl species and their roles in sarcoplasmic reticulum Ca2+ cycling defect in the diabetic heart","volume":"19","author":"Tian","year":"2014","journal-title":"Heart Fail Rev"},{"key":"10.1016\/j.acvd.2021.08.004_bib1160","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1093\/glycob\/cwq071","article-title":"Inhibition of phospholamban phosphorylation by O-GlcNAcylation: implications for diabetic cardiomyopathy","volume":"20","author":"Yokoe","year":"2010","journal-title":"Glycobiology"},{"key":"10.1016\/j.acvd.2021.08.004_bib1165","doi-asserted-by":"crossref","first-page":"44230","DOI":"10.1074\/jbc.M303810200","article-title":"Diabetes and the accompanying hyperglycemia impairs cardiomyocyte calcium cycling through increased nuclear O-GlcNAcylation","volume":"278","author":"Clark","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.acvd.2021.08.004_bib1170","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.ceca.2014.08.004","article-title":"Calcium signaling in diabetic cardiomyocytes","volume":"56","author":"Pereira","year":"2014","journal-title":"Cell Calcium"},{"key":"10.1016\/j.acvd.2021.08.004_bib1175","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1006\/jmcc.2000.1139","article-title":"Streptozotocin-induced changes in cardiac gene expression in the absence of severe contractile dysfunction","volume":"32","author":"Depre","year":"2000","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.acvd.2021.08.004_bib1180","first-page":"H1656","article-title":"Effects of diabetes on isometric tension as a function of [Ca2+] and pH in rat skinned cardiac myocytes","volume":"269","author":"Hofmann","year":"1995","journal-title":"Am J Physiol"},{"key":"10.1016\/j.acvd.2021.08.004_bib1185","first-page":"H2185","article-title":"Alterations in contractile properties and Ca2+ handling in streptozotocin-induced diabetic rat myocardium","volume":"277","author":"Ishikawa","year":"1999","journal-title":"Am J Physiol"},{"key":"10.1016\/j.acvd.2021.08.004_bib1190","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1161\/CIRCRESAHA.108.184978","article-title":"O-linked GlcNAc modification of cardiac myofilament proteins: a novel regulator of myocardial contractile function","volume":"103","author":"Ramirez-Correa","year":"2008","journal-title":"Circ Res"},{"key":"10.1016\/j.acvd.2021.08.004_bib1195","doi-asserted-by":"crossref","first-page":"3573","DOI":"10.2337\/db14-1107","article-title":"Removal of Abnormal Myofilament O-GlcNAcylation Restores Ca2+ Sensitivity in Diabetic Cardiac Muscle","volume":"64","author":"Ramirez-Correa","year":"2015","journal-title":"Diabetes"},{"key":"10.1016\/j.acvd.2021.08.004_bib1200","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1038\/nature12537","article-title":"Diabetic hyperglycaemia activates CaMKII and arrhythmias by O-linked glycosylation","volume":"502","author":"Erickson","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.acvd.2021.08.004_bib1205","first-page":"H2876","article-title":"High extracellular glucose impairs cardiac E-C coupling in a glycosylation-dependent manner","volume":"273","author":"Ren","year":"1997","journal-title":"Am J Physiol"},{"key":"10.1016\/j.acvd.2021.08.004_bib1210","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1113\/jphysiol.1993.sp019866","article-title":"Calcium and potassium currents in ventricular myocytes isolated from diabetic rats","volume":"470","author":"Jourdon","year":"1993","journal-title":"J Physiol"},{"key":"10.1016\/j.acvd.2021.08.004_bib1215","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1161\/01.RES.74.4.620","article-title":"Short-term diabetes alters K+ currents in rat ventricular myocytes","volume":"74","author":"Shimoni","year":"1994","journal-title":"Circ Res"},{"key":"10.1016\/j.acvd.2021.08.004_bib1220","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.ijcard.2018.02.099","article-title":"O-GlcNAcylation of cardiac Nav1.5 contributes to the development of arrhythmias in diabetic hearts","volume":"260","author":"Yu","year":"2018","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.acvd.2021.08.004_bib1225","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1056\/NEJMp2004889","article-title":"Assessing the Safety of Glucose-Lowering Drugs - A New Focus for the FDA","volume":"383","author":"Chong","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.acvd.2021.08.004_bib1230","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1161\/CIRCHEARTFAILURE.112.000162","article-title":"Comparative safety and effectiveness of metformin in patients with diabetes mellitus and heart failure: systematic review of observational studies involving 34,000 patients","volume":"6","author":"Eurich","year":"2013","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.acvd.2021.08.004_bib1235","doi-asserted-by":"crossref","first-page":"i3477","DOI":"10.1136\/bmj.i3477","article-title":"Diabetes treatments and risk of heart failure, cardiovascular disease, and all cause mortality: cohort study in primary care","volume":"354","author":"Hippisley-Cox","year":"2016","journal-title":"BMJ"},{"key":"10.1016\/j.acvd.2021.08.004_bib1240","doi-asserted-by":"crossref","first-page":"e005379","DOI":"10.1161\/JAHA.116.005379","article-title":"Comparative safety of sulfonylurea and metformin monotherapy on the risk of heart failure: a cohort study","volume":"6","author":"Roumie","year":"2017","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.acvd.2021.08.004_bib1245","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1038\/nrcardio.2017.211","article-title":"Effect of glucose-lowering therapies on heart failure","volume":"15","author":"Nassif","year":"2018","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.acvd.2021.08.004_bib1250","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1016\/S0140-6736(14)62225-X","article-title":"Heart failure and mortality outcomes in patients with type 2 diabetes taking alogliptin versus placebo in EXAMINE: a multicentre, randomised, double-blind trial","volume":"385","author":"Zannad","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.acvd.2021.08.004_bib1255","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1001\/jamacardio.2016.0103","article-title":"Association between sitagliptin use and heart failure hospitalization and related outcomes in Type 2 Diabetes Mellitus: secondary analysis of a randomized clinical trial","volume":"1","author":"McGuire","year":"2016","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.acvd.2021.08.004_bib1260","doi-asserted-by":"crossref","first-page":"e198","DOI":"10.1161\/CIRCULATIONAHA.115.015511","article-title":"Heart failure, saxagliptin, and diabetes mellitus: observations from the SAVOR-TIMI 53 randomized trial","volume":"132","author":"Scirica","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.acvd.2021.08.004_bib1265","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1001\/jama.2019.2942","article-title":"Effect of Additional Oral Semaglutide vs Sitagliptin on Glycated Hemoglobin in Adults With Type 2 Diabetes Uncontrolled With Metformin Alone or With Sulfonylurea: The PIONEER 3 Randomized Clinical Trial","volume":"321","author":"Rosenstock","year":"2019","journal-title":"JAMA"},{"key":"10.1016\/j.acvd.2021.08.004_bib1270","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1056\/NEJMoa1603827","article-title":"Liraglutide and cardiovascular outcomes in Type 2 diabetes","volume":"375","author":"Marso","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.acvd.2021.08.004_bib1275","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1056\/NEJMoa1607141","article-title":"Semaglutide and cardiovascular outcomes in patients with type 2 diabetes","volume":"375","author":"Marso","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.acvd.2021.08.004_bib1280","first-page":"2076","article-title":"Oral Semaglutide and Cardiovascular Outcomes in Type 2 Diabetes","volume":"381","author":"Husain","year":"2019","journal-title":"Reply. N Engl J Med"},{"key":"10.1016\/j.acvd.2021.08.004_bib1285","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0140-6736(19)31149-3","article-title":"Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial","volume":"394","author":"Gerstein","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.acvd.2021.08.004_bib1290","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1001\/jama.2016.15394","article-title":"Lack of benefit for liraglutide in heart failure-reply","volume":"316","author":"Margulies","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.acvd.2021.08.004_bib1295","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1002\/ejhf.657","article-title":"Effect of liraglutide, a glucagon-like peptide-1 analogue, on left ventricular function in stable chronic heart failure patients with and without diabetes (LIVE)-a multicentre, double-blind, randomised, placebo-controlled trial","volume":"19","author":"Jorsal","year":"2017","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.acvd.2021.08.004_bib1300","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1161\/CIRCULATIONAHA.117.032099","article-title":"Glucose-lowering therapies and heart failure in Type 2 diabetes mellitus: mechanistic links, clinical data, and future directions","volume":"137","author":"Vijayakumar","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.acvd.2021.08.004_bib1305","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1056\/NEJMoa1504720","article-title":"Empagliflozin, cardiovascular outcomes, and mortality in Type 2 diabetes","volume":"373","author":"Zinman","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.acvd.2021.08.004_bib1310","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1056\/NEJMoa1611925","article-title":"Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes","volume":"377","author":"Neal","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.acvd.2021.08.004_bib1315","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1056\/NEJMoa1812389","article-title":"Dapagliflozin and cardiovascular outcomes in Type 2 Diabetes","volume":"380","author":"Wiviott","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.acvd.2021.08.004_bib1320","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1161\/CIRCULATIONAHA.117.029190","volume":"136","author":"Kosiborod","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.acvd.2021.08.004_bib1325","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1056\/NEJMoa2022190","article-title":"Cardiovascular and renal outcomes with empagliflozin in heart failure","volume":"383","author":"Packer","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.acvd.2021.08.004_bib1330","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1056\/NEJMoa1911303","article-title":"Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction","volume":"381","author":"McMurray","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.acvd.2021.08.004_bib1335","doi-asserted-by":"crossref","first-page":"3419","DOI":"10.1093\/eurheartj\/ehaa584","article-title":"The interaction between dapagliflozin and blood pressure in heart failure: new evidence dissipating concerns","volume":"41","author":"Savarese","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1016\/j.acvd.2021.08.004_bib1340","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1016\/j.jacc.2019.08.001","article-title":"2019 ACC Expert Consensus Decision Pathway on risk assessment, management, and clinical trajectory of patients hospitalized with heart failure: a report of the American College of Cardiology Solution Set Oversight Committee","volume":"74","author":"Hollenberg","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.acvd.2021.08.004_bib1345","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.jacbts.2020.02.004","article-title":"Mechanisms of cardiovascular benefits of Sodium Glucose Co-Transporter 2 (SGLT2) Inhibitors: a state-of-the-art review","volume":"5","author":"Lopaschuk","year":"2020","journal-title":"JACC Basic Transl Sci"},{"key":"10.1016\/j.acvd.2021.08.004_bib1350","first-page":"320","article-title":"About the Belgian experience with SGLT2 inhibitors","volume":"14","author":"Scheen","year":"2020","journal-title":"Med des Mal Metab"}],"container-title":["Archives of Cardiovascular Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1875213621001479?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1875213621001479?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T13:47:43Z","timestamp":1761745663000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1875213621001479"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":135,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["S1875213621001479"],"URL":"https:\/\/doi.org\/10.1016\/j.acvd.2021.08.004","relation":{},"ISSN":["1875-2136"],"issn-type":[{"value":"1875-2136","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The role of hyperglycaemia in the development of diabetic cardiomyopathy","name":"articletitle","label":"Article Title"},{"value":"Archives of Cardiovascular Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.acvd.2021.08.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Masson SAS.","name":"copyright","label":"Copyright"}]}}